BackPacira BioSciences Overview

Pacira BioSciences Net Tangible Assets

Pacira BioSciences's net tangible assets is $670M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$671.98M
11.32% YoYΔ $-85.79M vs prior year quarter

Peer trimmed avg / median

Loading

Pacira BioSciences Net Tangible Assets History

Loading

Pacira BioSciences vs. peers: Net Tangible Assets Comparison

Loading

Pacira BioSciences Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pacira BioSciences (PCRX) FAQ

As of the most recent data (June 2026), PCRX shows a net tangible assets of $670M. That compares with $760M in the prior-year period — down 11.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PCRX's net tangible assets is now $670M (was $760M) — a 11.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pacira BioSciences is outperforming or lagging.

Tracking PCRX's net tangible assets over time shows whether Pacira BioSciences is scaling, shrinking, or reshaping that part of the business. The current reading is $670M That compares with $760M in the prior-year period — down 11.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Pacira BioSciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $670M) with ownership activity and broader fundamentals.

Pacira BioSciences's net tangible assets is $670M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.